Study guide
POAG, target pressure and normal-tension disease
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
POAG, target pressure and normal-tension disease
Key Takeaways Explain This Topic AI
POAG requires open-angle assessment and characteristic damage after secondary causes are considered.
Target pressure is individualized to baseline, damage, progression and remaining lifetime.
Normal measured pressure does not exclude glaucoma, but atypical pallor or fields require alternative-cause investigation.
Last updated: October 2026
Glaucoma represents a leading cause of irreversible blindness worldwide, encompassing a heterogeneous group of progressive optic neuropathies unified by accelerated apoptosis of retinal ganglion cells (RGCs), axonal loss at the lamina cribrosa, and characteristic functional visual field loss. In the European population, Primary Open-Angle Glaucoma (POAG) represents the predominant phenotypic entity, accounting for more than 75% of all glaucoma cases. Managing this chronic, asymptomatic disorder requires a sophisticated understanding of aqueous dynamics, risk stratification, target intraocular pressure (IOP) calculation, and systemic vascular comorbidities.
POAG: Definition, Pathophysiology & Diagnostic Criteria
According to the European Glaucoma Society (EGS) guidelines, Primary Open-Angle Glaucoma is defined as a chronic, progressive, multifactorial optic neuropathy occurring in adult individuals in the absence of identifiable secondary causes, fulfilling three cardinal clinical parameters:
Open Anterior Chamber Angle : Gonioscopic visualization of the trabecular meshwork without iridotrabecular contact, peripheral anterior synechiae (PAS), neovascularisation, or heavy pathological pigmentation across at least three quadrants (Shaffer Grade 3 to 4; Spaeth grading displaying a visible scleral spur or ciliary body band).
Characteristic Glaucomatous Structural Optic Neuropathy : Thinning or excavation of the neuroretinal rim, vertical elongation of the optic cup, focal notching, cup-to-disc ratio (CDR) asymmetry exceeding 0.2 between fellow eyes, breach of the physiological ISNT rule (Inferior ≥ \ge ≥ Superior ≥ \ge ≥ Nasal ≥ \ge ≥ Temporal neuroretinal rim width), localized retinal nerve fibre layer (RNFL) bundle defects, and disc (Drance) haemorrhages crossing the scleral ring.
Corresponding Functional Perimetric Deficits : Visual field defects on Standard Automated Perimetry (SAP) matching the structural topography of RNFL loss, such as paracentral scotomas, nasal steps, and arcuate (Bjerrum) scotomas respecting the horizontal raphe.
Historically, elevated intraocular pressure ( > 21 >21 > 21 mmHg) was considered a diagnostic requirement. Under modern EGS definitions, elevated IOP is understood as the most important modifiable causal risk factor , rather than an obligate diagnostic criterion. Approximately 30% to 50% of individuals diagnosed with open-angle glaucoma in European epidemiological surveys manifest baseline untreated IOP within the statistically normal range ( ≤ 21 \le 21 ≤ 21 mmHg).
Risk Assessment in OHT and POAG
Age, IOP, family history, ancestry, myopia and corneal factors influence risk, with different predictive value for development and progression. Ocular-hypertension risk calculators apply to their validated populations and use factors such as age, IOP, CCT, vertical cup-to-disc ratio and field pattern standard deviation. They are not diagnostic tests for a suspect with a different secondary mechanism.
Document untreated pressure where feasible, corneal thickness, angles, disc/RNFL and reliable baseline fields. Preperimetric glaucoma may have convincing structural damage before repeatable field loss. Follow-up depends on lifetime risk, severity and the rate of change, not an annual schedule for every eye.
The Target IOP Concept
Target IOP is an individual estimate of the pressure likely to protect useful vision over the patient's lifetime. Consider damage severity, baseline IOP, measured progression, age/life expectancy, fellow-eye vision, adverse effects and patient preferences. Review the target at monitoring visits. Confirm apparent progression and measurement quality before escalating treatment.
A target from 30 to 12 mmHg represents a 60% reduction, not 40–50%. This is an illustrative calculation, not a universal EGS recommendation. Advanced fixation-threatening disease often needs lower pressures than early disease, but pressure bands alone cannot define success. A field slope of −0.5 dB/year may be important in a young patient or a severely damaged eye. Discuss treatment burden, surgery, adherence and monitoring rather than labelling that rate automatically stable.
See the EGS sixth-edition target-pressure guidance .
Normal-Tension Glaucoma (NTG)
Normal-Tension Glaucoma (NTG) is classified under EGS taxonomy as a phenotypic subset within the open-angle glaucoma spectrum characterized by glaucomatous optic neuropathy, nerve fibre layer atrophy, and visual field loss occurring in the presence of untreated IOP consistently ≤ 21 \le 21 ≤ 21 mmHg across repeated diurnal testing.
Landmark Evidence: The CNTGS Trial
The landmark Collaborative Normal-Tension Glaucoma Study (CNTGS) definitively established that intraocular pressure plays an active role in NTG. The trial evaluated whether lowering IOP alters the natural history of disease in patients with progressive or centrally threatening NTG:
Patients randomized to a 30% IOP reduction (achieved via topical medications, laser trabeculoplasty, or filtration surgery) exhibited a 12% rate of confirmed visual field progression at 5 years , compared to a 35% rate of progression in untreated controls ( p < 0.001 p < 0.001 p < 0.001 ).
A critical secondary finding of the CNTGS was that a substantial proportion of untreated NTG patients (65%) did not progress significantly over the 5-year observation window, underscoring the clinical heterogeneity of the condition and the importance of establishing confirmed progression before initiating aggressive surgical therapy.
Distinct Clinical & Morphological Hallmarks of NTG
Compared to high-tension POAG, eyes with NTG present distinct structural and functional characteristics:
Optic Disc Features : Discs are often larger with thinner, flatter neuroretinal rims; focal deep ischemic notching is common, particularly in the inferotemporal and superotemporal sectors; acquired pits of the optic nerve (APON) occur with higher frequency; and Drance (splinter) disc haemorrhages are observed 3 to 5 times more frequently than in high-tension POAG.
Perimetric Profile : Scotomas in NTG tend to be closer to fixation, deeper, steeper, and more localized paracentrally, contrasting with the broader arcuate step patterns of high-tension POAG.
Systemic Vascular Risk Factors & Vascular Dysregulation
While IOP lowering remains effective, non-IOP-dependent vascular factors are central to NTG pathogenesis:
Flammer Syndrome (Primary Vascular Dysregulation) : A systemic vascular phenotype characterized by abnormal microvascular autoregulation. Clinical features include cold hands and feet (peripheral vasospasm), low body mass index (BMI), decreased thirst sensation, altered circadian vascular resistance, and heightened sensitivity to cold, physical stress, or medications.
Vasospastic Disorders : Strongly correlated with classical Raynaud phenomenon and a personal history of migraine headaches (especially with visual aura).
Nocturnal systemic hypotension: Low perfusion pressure and substantial nocturnal blood-pressure dips are associated with progression in some patients. The commonly used estimate O P P = 2 3 M A P − I O P OPP = \frac{2}{3}MAP - IOP OPP = 3 2 M A P − I OP is not a direct measurement of optic-nerve perfusion and varies with posture. Review suspected excessive dipping with the treating physician; do not independently stop or reschedule antihypertensives from a fixed diastolic threshold.
Obstructive sleep apnoea: Intermittent hypoxia and vascular dysregulation are possible contributors. Ask about symptoms and arrange appropriate systemic assessment; prevalence and the strength of associations depend on the studied population.
Differential Diagnosis of Suspected NTG: Red Flags & Mimics
Because non-glaucomatous optic neuropathies can simulate the cupping and visual field loss of NTG, a meticulous differential workup is mandatory. The clinician must systematically evaluate for alternative or masquerading etiologies:
Clinical Entity Primary Etiological Mechanism Distinctive Differentiating Features
"Burnt-Out" High-Tension Glaucoma Past resolved episodes of severe IOP elevation History of remote blunt trauma (angle recession), previous uveitis, pigment dispersion, or remote corticosteroid use
Spurious Normal IOP (Masked OHT) Thin central corneal thickness (CCT < 500 μ m <500\ \mu\text{m} < 500 μ m ) or prior corneal refractive surgery Topographical evidence of prior LASIK/PRK ablation; altered corneal thickness and biomechanics can bias applanation readings; no universal correction factor supplies a true IOP
Compressive Intracranial Lesions Extrinsic compression of the optic nerve, chiasm, or tract by pituitary adenoma or meningioma Pallor of neuroretinal rim out of proportion to cupping ; visual field defects respecting the vertical midline ; dyschromatopsia
Non-Arteritic AION (NAION) Posterior ciliary artery microvascular infarction Sudden, painless, non-progressive vision loss; classic altitudinal visual field defect ; crowded fellow eye ("disc at risk")
Hereditary Neuropathies (DOA / LHON) Mitochondrial dysfunction ( OPA1 nuclear gene or mtDNA 11778, 14484, 3460 mutations) Bilateral symmetrical temporal wedge optic atrophy; tritan dyschromatopsia; cecocentral scotomas; positive family pedigree
Toxic / Nutritional Neuropathies Mitochondrial toxicity (methanol, ethambutol, tobacco-alcohol amblyopia, B12 deficiency) Symmetrical bilateral central/cecocentral scotomas; marked red-green dyschromatopsia; generalized temporal pallor
Caution
Red Flags Demanding Urgent Neuroimaging (MRI Brain and Orbits with Gadolinium):
Neuroretinal rim pallor exceeding the degree of cupping (glaucoma causes cupping with a preserved, pink remaining rim; pallor indicates primary optic atrophy).
Visual field defects respecting the vertical midline (bitemporal hemianopia or homonymous defects).
Visual acuity loss disproportionate to the extent of optic nerve head excavation (e.g., visual acuity < 6 / 18 <6/18 < 6/18 with mild cupping).
Rapid, unilateral, or atypical disease progression in the absence of disc haemorrhages or elevated IOP.
Young patient age ( < 50 <50 < 50 years) at presentation without family history of glaucoma.